Rochelle Collantes

1.4k total citations
19 papers, 1.1k citations indexed

About

Rochelle Collantes is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Rochelle Collantes has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 9 papers in Hepatology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Rochelle Collantes's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (5 papers). Rochelle Collantes is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (5 papers). Rochelle Collantes collaborates with scholars based in United States and United Kingdom. Rochelle Collantes's co-authors include Zobair M. Younossi, Hazem Elariny, Vikas Chandhoke, Zachary Goodman, Janus P. Ong, Ancha Baranova, Mohammed Jarrar, Maria Stepanova, Yun Fang and Abraham Younoszai and has published in prestigious journals such as Hepatology, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Rochelle Collantes

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rochelle Collantes United States 13 938 378 332 195 188 19 1.1k
Kai En Chan Singapore 16 843 0.9× 343 0.9× 422 1.3× 150 0.8× 147 0.8× 46 1.1k
JANE HOLMES-WALKER Australia 3 835 0.9× 217 0.6× 506 1.5× 128 0.7× 139 0.7× 7 958
Kerry–Lee Milner Australia 8 676 0.7× 217 0.6× 304 0.9× 299 1.5× 176 0.9× 13 1.0k
Hazem Elariny United States 18 1.1k 1.2× 308 0.8× 461 1.4× 323 1.7× 256 1.4× 26 1.5k
M Rosselli Argentina 10 790 0.8× 161 0.4× 419 1.3× 148 0.8× 174 0.9× 10 1.0k
A Austin United States 10 569 0.6× 195 0.5× 352 1.1× 143 0.7× 82 0.4× 22 861
E. Vanni Italy 7 722 0.8× 142 0.4× 430 1.3× 211 1.1× 120 0.6× 23 867
Alessandra Marrazzo Italy 5 667 0.7× 263 0.7× 301 0.9× 90 0.5× 123 0.7× 8 796
T.C.M.A. Schreuder Netherlands 15 702 0.7× 258 0.7× 313 0.9× 112 0.6× 86 0.5× 21 1.1k
Julio San Martino Argentina 13 1.0k 1.1× 237 0.6× 459 1.4× 144 0.7× 177 0.9× 17 1.5k

Countries citing papers authored by Rochelle Collantes

Since Specialization
Citations

This map shows the geographic impact of Rochelle Collantes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rochelle Collantes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rochelle Collantes more than expected).

Fields of papers citing papers by Rochelle Collantes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rochelle Collantes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rochelle Collantes. The network helps show where Rochelle Collantes may publish in the future.

Co-authorship network of co-authors of Rochelle Collantes

This figure shows the co-authorship network connecting the top 25 collaborators of Rochelle Collantes. A scholar is included among the top collaborators of Rochelle Collantes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rochelle Collantes. Rochelle Collantes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lieberman, Daniel Z., et al.. (2014). Treatment Preferences among Problem Drinkers in Primary Care. The International Journal of Psychiatry in Medicine. 47(3). 231–240. 12 indexed citations
2.
Collantes, Rochelle, et al.. (2009). Understanding Viral Hepatitis. The Nurse Practitioner. 34(12). 23–31. 2 indexed citations
3.
Younossi, Zobair M., Ancha Baranova, Arian Afendy, et al.. (2009). Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon‐alfa and ribavirin†. Hepatology. 49(3). 763–774. 36 indexed citations
4.
Younossi, Zobair M., Fatema Nader, Chunhong Bai, et al.. (2008). A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment. Journal of Viral Hepatitis. 15(5). 370–378. 30 indexed citations
5.
Kallman, Jillian, et al.. (2007). Health‐related quality of life in patients with non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 26(6). 815–820. 96 indexed citations
6.
Baranova, Ancha, Karen Schlauch, Hazem Elariny, et al.. (2007). Gene Expression Patterns in Hepatic Tissue and Visceral Adipose Tissue of Patients with Non-Alcoholic Fatty Liver Disease. Obesity Surgery. 17(8). 1111–1118. 50 indexed citations
7.
Calvert, Valerie, Rochelle Collantes, Hazem Elariny, et al.. (2007). A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis. Hepatology. 46(1). 166–172. 42 indexed citations
8.
Jarrar, Mohammed, Ancha Baranova, Rochelle Collantes, et al.. (2007). Adipokines and cytokines in non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 27(5). 412–421. 350 indexed citations
9.
Jarrar, Mohammed, Benjamin L. Ranard, Maria Stepanova, et al.. (2007). [718] HEPATIC MANIFESTATION OF METABOLIC SYNDROME (MS): NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND SERUM ADIPOKINES. Journal of Hepatology. 46. S271–S271. 1 indexed citations
10.
Bai, Changsen, Chitra Kumar Gurung, Manirath Srishord, et al.. (2007). [621] THE USE OF GROWTH FACTORS (GF) IN THE RE-TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C (CHC) WHO ARE PREVIOUS NON RESPONDERS (NR) TO COMBINATION THERAPY. Journal of Hepatology. 46. S235–S235. 1 indexed citations
11.
Baranova, Ancha, Karen Schlauch, Hazem Elariny, et al.. (2006). Gene Expression of Leptin, Resistin, and Adiponectin in the White Adipose Tissue of Obese Patients with Non-Alcoholic Fatty Liver Disease and Insulin Resistance. Obesity Surgery. 16(9). 1118–1125. 91 indexed citations
12.
Collantes, Rochelle & Zobair M. Younossi. (2005). The Use of Growth Factors to Manage the Hematologic Side Effects of PEG-Interferon Alfa and Ribavirin. Journal of Clinical Gastroenterology. 39(Supp 1). S9–S13. 40 indexed citations
13.
Baranova, Ancha, et al.. (2005). Microarray technology in the study of obesity and non‐alcoholic fatty liver disease. Liver International. 25(6). 1091–1096. 13 indexed citations
14.
Baranova, Ancha, Rochelle Collantes, Hazem Elariny, et al.. (2005). Obesity-related Differential Gene Expression in the Visceral Adipose Tissue. Obesity Surgery. 15(6). 758–765. 55 indexed citations
15.
Ong, Janus P., Hazem Elariny, Rochelle Collantes, et al.. (2005). Predictors of Nonalcoholic Steatohepatitis and Advanced Fibrosis in Morbidly Obese Patients. Obesity Surgery. 15(3). 310–315. 242 indexed citations
16.
Ong, Janus P., et al.. (2005). High Rates of Uninsured Among HCV-Positive Individuals. Journal of Clinical Gastroenterology. 39(9). 826–830. 30 indexed citations
17.
Collantes, Rochelle, Janus P. Ong, & Zobair M. Younossi. (2004). Nonalcoholic fatty liver disease and the epidemic of obesity.. Cleveland Clinic Journal of Medicine. 71(8). 657–664. 33 indexed citations
18.
Collantes, Rochelle, et al.. (2004). The role of physician extenders in managing patients with chronic hepatitis C.. Cleveland Clinic Journal of Medicine. 71(Suppl_3). S33–S33. 11 indexed citations
19.
Collantes, Rochelle & Zobair M. Younossi. (2004). How great is the risk of transmitting the hepatitis C virus sexually?. Cleveland Clinic Journal of Medicine. 71(2). 160–161. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai En Chan Breakdown of academic impact, for papers by JANE HOLMES-WALKER Breakdown of academic impact, for papers by Kerry–Lee Milner Breakdown of academic impact, for papers by Hazem Elariny Breakdown of academic impact, for papers by M Rosselli Breakdown of academic impact, for papers by A Austin Breakdown of academic impact, for papers by E. Vanni Breakdown of academic impact, for papers by Alessandra Marrazzo Breakdown of academic impact, for papers by T.C.M.A. Schreuder Breakdown of academic impact, for papers by Julio San Martino
Rankless by CCL
2026